一种基于设计质量和敏捷Scrum模式的混合创新方法,用于药品开发
Thierry Bastogne1, Laurène Wagner2,3, Samir Acherar2
1CRAN UMR 7039, CNRS, Université de Lorraine, 54000, Nancy, France. thierry.bastogne@univ-lorraine.fr.
Scientific reports
|September 29, 2025
概括
本研究引入了一个敏捷的设计质量 (QbD) 框架,以简化制药开发. 这种代方法,使用代方法.
科学领域:
- 制药科学 制药科学
- 药物开发 药物开发
- 监管科学 监管科学
背景情况:
- 监管机构推通过设计质量 (QbD) 制药创新.
- 当前的QbD方法在应用的早期阶段可能是复杂和有限的.
- 需要一个更灵活和结构化的QbD方法.
研究的目的:
- 为制药 QbD 方法提出一个敏捷的范式.
- 加强QbD的结构组织,以简化使用和更广泛的应用,包括临床前阶段.
- 将增量和代方法集成到QbD中.
主要方法:
- 开发了一个敏捷的QbD范式,使用称为"冲刺"的简短研究.
- 使用技术准备水平 (TRL) 尺度进行索引冲刺.
- 每个冲刺都涉及目标产品配置文件的开发,变量识别,实验设计,执行和为决策提供统计分析.
主要成果:
- 在六个冲刺中应用敏捷的QbD方法对放射性药物开发.
- 从最初的产品概念 (TRL 2) 发展到原型 (TRL 4).
- 证明了增量和代QbD方法的实际相关性.
结论:
- 敏捷的QbD范式为药物创新的知识管理提供了一个有效的工具.
- 这种方法简化了QbD的实施,并将其应用扩展到早期开发阶段.
- 该方法促进了关于项目进展,代或终止的知情决策.
相关概念视频
Biopharmaceutical Factors Influencing Drug Product Design: Overview
233
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
233
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Clinically Relevant Drug Product Specifications: Methods of Establishment
205
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
205
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Drug Products: Biologics, Biosimilars and Interchangeables
235
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
235


